TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $17 to $19.
Stocks · News reference
Surgery Partners To Sell Ownership Interests In Mountain View Hospital And Idaho Falls Community Hospital To Intermountain Health; Deal Values Combined Idaho Falls Facilities At ~$1.15B, Total Consideration To Surgery Partners ~$795M
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced it, along with its existing partner Intermountain
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19
RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $20 to $19.
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $18 price target.
8-K filing — Surgery Partners, Inc. (SGRY)
Filed: 2026-08-10 AccNo: 0001638833-26-000074 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits